首頁
CIBMTR (Center for International Bloo...

11月 2025CIBMTR (Center for Inter...的市場佔有率分析

the center for international blood and marrow transplant research (cibmtr) is a collaborative resource of data and experts supporting research in cellular therapies to improve patient outcomes.

健康 > 醫學

域名cibmtr.org

成立年份2004

僱員51 - 200

年度營收--

CIBMTR (Center for International Bloo...

CIBMTR (Center for International Bloo...（包含公司地區）

cibmtr.org

查看更多網站流量與參與度資訊

CIBMTR (Center for International Bloo...的熱門網域總造訪量

了解CIBMTR (Center for International Bloo...市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

cibmtr.org12.7K

透過銷售情報查看更多內容

CIBMTR (Center for International Bloo...的熱門網域平均造訪時長

分析CIBMTR (Center for International Bloo...參與度指標。

過去 3 個月平均造訪時長

子公司細目

cibmtr.org00:00:52

透過銷售情報查看更多內容

CIBMTR (Center for International Bloo...的熱門網域平均頁面瀏覽量

了解CIBMTR (Center for International Bloo...如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

cibmtr.org2.08

透過銷售情報查看更多內容

CIBMTR (Center for International Bloo...按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

hematology.org公司名American Society of Hematology僱員51 - 200總部美國, 哥倫比亞特區, Washington年度營收$50M - $75M訪問總量663.2K健康 > 醫學

使用的熱門技術CIBMTR (Center for International Bloo...

这些是CIBMTR (Center for International Bloo...顶级域名使用的行业网站技术

付款與貨幣 (22)

PayPal

轉換與分析 (4)

Google Analytics

內容管理系統 (3)

Kentico

小工具 (2)

reCAPTCHA

更多技術

12

檢視所有

新聞與訊號來自CIBMTR (Center for International Bloo...

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Center for International Blood and Marrow Transplant Research hired Kwang Woo Ahn as Chief Statistical Director on Sep 1st '24.The Medical College of Wisconsin is pleased to announce that Dr. Kwang Woo Ahn has been appointed Chief Statistical Director of the CIBMTR, effective September 1, 2024.

新聞Center for International Blood and Marrow Transplant Research launched chimeric antigen receptor T cell therapy on Mar 22nd '22.Recently, the CIBMTR expanded to include data for other cell therapies, such as chimeric antigen receptor T cell (CAR-T) therapy.

新聞Emmes Corporation partners with Center for International Blood and Marrow Transplant Research.Emmes has partnered with the Center for International Blood and Marrow Transplant Research (CIBMTR) and NMDP/Be The Match to develop and implement a study enrolling patients and collecting samples to determine how these immunocompromised patients respond to the COVID-19 vaccines.